Seelos Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$37,882,000 and profit margin reached -1720%. Total operating expenses were $12,585,000.

Profit Margin

Seelos Therapeutics, Inc. (NASDAQ:SEEL): Profit margin
2014 9.25M -21.78M -235.3%
2015 4.83M -19.02M -393.12%
2016 5.76M -7.43M -128.98%
2017 0 321K
2018 0 -9.24M
2019 375K -50.38M -13435.47%
2020 0 -19.22M
2021 0 -67.53M
2022 0 -76.13M
2023 2.20M -37.88M -1719.56%

SEEL Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
2.20M000375K005.76M4.83M9.25M
Cost of revenue
30.11M53K0022.56M0117K3.89M922K918K
Gross profit
-27.91M-53K00-22.18M0-117K1.87M3.91M8.34M
Operating exp.
Research and development
30.11M58.62M46.64M10.98M22.56M1.22M3.46M6.83M14.64M21.28M
Selling and marketing
-57K000000000
Total operating expenses
12.58M70.91M61.66M18.75M29.74M9.14M10.67M15.26M25.16M30.9M
Operating income
-40.49M-70.91M-61.66M-18.75M-29.74M-9.14M-10.67M-13.40M-21.35M-22.55M
Other income (expenses), net
2.61M-2.61M-4.37M-342K-21.13M-70K-1.07M7.44M2.32M82K
Income before tax
-37.88M-73.53M-66.04M-19.10M-50.88M-9.21M-11.74M-7.43M-19.02M-22.47M
Income tax expense
02.60M1.48M119K-497K-70K-11.91M1M781K-691K
Net income
-37.88M-76.13M-67.53M-19.22M-50.38M-9.24M321K-7.43M-19.02M-21.78M
Earnings per share
Basic EPS
-7.73-21.48-22.29-12.88-74.43-89.9724.32-3.96-3.44K-165
Diluted EPS
-7.73-21.48-22.29-12.88-74.43-89.9724.32-3.96-3.44K-165
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source